A Study to Confirm the Long-term Safety and Effectiveness of Kalydeco in Patients With Cystic Fibrosis Who Have an R117H-CFTR Mutation, Including Pediatric Patients

Clinical trial NCT02722057 · COMPLETED

Trial details

NCT number: NCT02722057
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Study type: OBSERVATIONAL

Cystic Fibrosis

Start date: 2015-12-01
Primary completion: 2019-12-01
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.